Protecting decades of life gained through valve surgery while reducing the cost of anticoagulation management
Mechanical heart valves represent one of modern medicine’s great successes. Through advanced cardiac surgery, patients with serious valvular heart disease often gain decades of additional life expectancy, productivity, and quality of life. Significant healthcare resources are invested in diagnosis, surgery, intensive care, rehabilitation, and long-term follow-up to achieve this outcome.
The value created by that investment depends on one critical requirement: maintaining safe and effective lifelong anticoagulation therapy.
Our White Paper covers:
✅ 12 years of real-world clinical experience
✅ More than 82,000 patient-years of anticoagulation management
✅ Direct savings potential of 315 €/patient/year
Complete the form below to receive your copy.
